Mast Therapeutics (MSTX) Reports Q4 Loss of $0.02/Share

Mast Therapeutics (NYSE: MSTX) reported Q4 EPS of ($0.02), versus ($0.06) reported last year.

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'